Skip to content
10-Q

Quarterly Report

IDEAYA Biosciences, Inc. IDYA

0001193125-26-206357

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 87.86M sh
Shares Diluted Q1 2026 · Mar 31, 2026 88.7M sh
Shares Diluted Q1 2026 · Mar 31, 2025 88.36M sh
Capex Q1 2026 · Mar 31, 2026 $967K
Capex Q1 2026 · Mar 31, 2025 $1.33M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$75.17M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$60.34M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $157.52M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $112.83M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $130M
Stockholders Equity Q1 2026 · Mar 31, 2026 $937.27M
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.02B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.02B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.06B
Current Liabilities Q1 2026 · Mar 31, 2026 $64.83M
Current Liabilities Q1 2026 · Dec 31, 2025 $58.82M
Total Liabilities Q1 2026 · Mar 31, 2026 $93.08M
Total Liabilities Q1 2026 · Dec 31, 2025 $86.39M
Current Assets Q1 2026 · Mar 31, 2026 $696.11M
Current Assets Q1 2026 · Dec 31, 2025 $666.73M
Total Assets Q1 2026 · Mar 31, 2026 $1.03B
Total Assets Q1 2026 · Dec 31, 2025 $1.11B
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.11
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.82
Eps Basic Q1 2026 · Mar 31, 2026 −$1.11
Eps Basic Q1 2026 · Mar 31, 2025 −$0.82
Sga Expense Q1 2026 · Mar 31, 2026 $19.38M
Sga Expense Q1 2026 · Mar 31, 2025 $13.5M
Rd Expense Q1 2026 · Mar 31, 2026 $95.73M
Rd Expense Q1 2026 · Dec 31, 2025 $86.6M
Rd Expense Q1 2026 · Mar 31, 2025 $70.89M
Net Income Q1 2026 · Mar 31, 2026 −$98.54M
Net Income Q1 2026 · Mar 31, 2025 −$72.18M
Operating Income Q1 2026 · Mar 31, 2026 −$108.54M
Operating Income Q1 2026 · Mar 31, 2025 −$84.39M
Revenue Q1 2026 · Mar 31, 2026 $6.56M